SHARP study

SHARP concluded that around a quarter of all heart attacks, strokes, and operations to open blocked arteries could be avoided in people with chronic kidney disease by using the combination of ezetimibe and simvastatin to lower blood cholesterol levelsSharp Collaborative Group.  Am Heart J. 2010 Nov;160(5):785-794